BSE filing, BSE: 542446. Summary written from the filing by ALFA Finder's alert engine.
Jonjua Overseas Ltd: key numbers
- Share price
- ₹2.83
- Market cap
- ₹9.97 Cr
- Revenue (annual)
- ₹21.21 Cr
- Net profit (annual)
- ₹8.07 Cr
- P/E (TTM)
- 1.2×Sector 43.1×
- Promoter holding
- 29.67%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jonjua Overseas Ltd
All →Jonjua Overseas Board Meeting Date
Jonjua Overseas will hold a board meeting on November 5, 2026, to consider its fundraising committee's financing recommendation. The filing is an advance intimation, and the agenda items are only proposed.
Jonjua Overseas Other Announcement
Jonjua Overseas Ltd has filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory disclosure requirements.
Jonjua Overseas Partnership
Jonjua Overseas Limited signed an MOU with Catobo LLP to collaborate on developing helipad and heliport infrastructure, combining their engineering and construction expertise.
- From
- Catobo LLP
Jonjua Overseas Board Meeting Outcome
Jonjua Overseas' board meeting outcome reports the formation of a Fund Raising Committee and approval for subscribing to a Rights Issue in a private company.
Jonjua Overseas Board Meeting Date
Jonjua Overseas Ltd has scheduled a Board Meeting for 18th September, 2026, to discuss fundraising proposals and the subscription to a rights issue.
Jonjua Overseas Board Meeting Outcome
Jonjua Overseas approved bonus shares at 7:24 ratio and acquisition of VTOL/STOL helipad technology for ₹19.14 Crore from its MD. The acquisition represents 87% of annual turnover.
- Value
- ₹19.14 Cr
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.